Canadian Chemical Blueprint Condemned

QUEBEC CITY—A proposed blueprint for Canadian chemical research has been condemned by two of the organizations that commissioned it. The committee that wrote the report said Canadian academic research compared unfavorably with work done in the United States. It recommended a more selective funding structure that would bolster top-notch programs and allow them to compete internationally. It acknowledged that the policy would hurt smaller departments, whose faculty would receive fewer, small

Written byRichard Stevenson
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The committee that wrote the report said Canadian academic research compared unfavorably with work done in the United States. It recommended a more selective funding structure that would bolster top-notch programs and allow them to compete internationally. It acknowledged that the policy would hurt smaller departments, whose faculty would receive fewer, smaller grants.

But its assumptions and conclusions have been attacked by researchers and the nation's major grant-awarding body, the Natural Sciences and Engineering Research Council (NSERC). In 1981 NSERC joined with the Canadian Council of University Chemistry Chairmen (CCUCC), Chemical Institute of Canada (CIC) and Royal Society of Canada in inviting 10 prominent chemistry professors to "chart future directions for chemistry in Canada and identify the associated requirements for financial resources." The panel was led by Howard C. Clark of Daihousie University and James A. Morrison, formerly of McMaster University.

The report, Towards Excellence in Chemistry, appeared last September ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies